CA SB 1023
enactedHealth care coverage: antiretroviral drugs, drug devices, and drug products.
California · 2025-2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did CA SB 1023 pass?
Yes. CA SB 1023 has been enacted into law. Latest recorded action (2026-09-26): Chaptered by Secretary of State. Chapter 470, Statutes of 2026.
What is CA SB 1023 about?
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law generally prohibits a health care service plan, excluding a Medi-Cal managed care plan, or health insurer from subjecting antiretroviral drugs that are medically necessary for the prevention of HIV/AIDS, including preexposure prophylaxis or postexposure prophylaxis, to prior authorization or step therapy. Under existing law, a health care service plan or health insurer is not required to cover all of the therapeutically equivalent versions of those drugs without prior authorization or step therapy if at least one is covered without prior authorization or step therapy. This bill would instead prohibit a health care service plan, excluding a Medi-Cal managed care plan, or health insurer from subjecting antiretroviral drugs, drug devices, or drug products that are medically necessary for the prevention of HIV/AIDS to prior authorization or step therapy. The bill would require, for a health care service plan contract or health insurance policy issued, amended, or renewed on or after January 1, 2027, a non-self-administered antiretroviral drug, drug device, or drug product that is approved by the United States Food and Drug Administration for the prevention of HIV/AIDS to be covered under both the plan or policy's medical benefit and prescription drug benefit, and if obtained under the plan or policy's drug benefit, would require the drug, device, or product to be dispensed and administered by a health care provider acting within the scope of their license. Because a willful violation of these provisions by a health care service plan would be a crime, this bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.
Who sponsors CA SB 1023?
Laird is the primary sponsor of CA SB 1023, joined by 1 cosponsor.
Description
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law generally prohibits a health care service plan, excluding a Medi-Cal managed care plan, or health insurer from subjecting antiretroviral drugs that are medically necessary for the prevention of HIV/AIDS, including preexposure prophylaxis or postexposure prophylaxis, to prior authorization or step therapy. Under existing law, a health care service plan or health insurer is not required to cover all of the therapeutically equivalent versions of those drugs without prior authorization or step therapy if at least one is covered without prior authorization or step therapy. This bill would instead prohibit a health care service plan, excluding a Medi-Cal managed care plan, or health insurer from subjecting antiretroviral drugs, drug devices, or drug products that are medically necessary for the prevention of HIV/AIDS to prior authorization or step therapy. The bill would require, for a health care service plan contract or health insurance policy issued, amended, or renewed on or after January 1, 2027, a non-self-administered antiretroviral drug, drug device, or drug product that is approved by the United States Food and Drug Administration for the prevention of HIV/AIDS to be covered under both the plan or policy's medical benefit and prescription drug benefit, and if obtained under the plan or policy's drug benefit, would require the drug, device, or product to be dispensed and administered by a health care provider acting within the scope of their license. Because a willful violation of these provisions by a health care service plan would be a crime, this bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.
- Introduced
- 2026-02-10
- Latest action
- 2026-09-26 — Chaptered by Secretary of State. Chapter 470, Statutes of 2026.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Lairdauthor
- Mark Gonzálezprincipal coauthor
Committees
Not provided by source.
Action timeline
Newest first
2026-09-26
Chaptered by Secretary of State. Chapter 470, Statutes of 2026.
became-law
2026-09-26
Approved by the Governor.
executive-signature
2026-08-30
Enrolled and presented to the Governor at 6 p.m.
executive-receipt
2026-08-25
Reconsideration granted. (Ayes 37. Noes 0.)
2026-08-25
Assembly amendments concurred in. (Ayes 29. Noes 0.) Ordered to engrossing and enrolling.
amendment-passage,committee-passage,committee-passage-favorable
2026-08-25
Assembly amendments concurred in. (Ayes 31. Noes 1.) Ordered to engrossing and enrolling.
amendment-passage,committee-passage,committee-passage-favorable
2026-08-25
Motion to reconsider made by Senator Ashby.
2026-08-25
Assembly amendments concurred in. (Ayes 31. Noes 1. Page 5755.) Ordered to engrossing and enrolling.
2026-08-25
Reconsideration granted. (Ayes 38. Noes 0. Page 5757.)
2026-08-25
Assembly amendments concurred in. (Ayes 30. Noes 0. Page 5757.) Ordered to engrossing and enrolling.
2026-08-25
Reconsideration granted. (Ayes 38. Noes 0.)
2026-08-25
Assembly amendments concurred in. (Ayes 30. Noes 0.) Ordered to engrossing and enrolling.
amendment-passage,committee-passage,committee-passage-favorable
2026-08-24
Read third time. Passed. Ordered to the Senate.
passage,reading-1,reading-3
2026-08-24
In Senate. Concurrence in Assembly amendments pending.
2026-08-24
Read third time. Passed. (Ayes 62. Noes 3. Page 6392.) Ordered to the Senate.
passage,reading-1,reading-3
2026-08-18
Read third time and amended.
amendment-passage,reading-1,reading-3
2026-08-18
Ordered to third reading.
reading-1,reading-3
2026-08-13
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2026-08-13
From committee: Do pass. (Ayes 11. Noes 1.) (August 13).
committee-passage,committee-passage-favorable
2026-08-13
Assembly Rule 63 suspended.
2026-07-01
July 1 set for first hearing. Placed on suspense file.
2026-06-10
From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (June 9). Re-referred to Com. on APPR.
committee-passage,committee-passage-favorable,referral-committee
2026-05-26
Referred to Com. on HEALTH.
referral-committee
2026-05-19
In Assembly. Read first time. Held at Desk.
reading-1
2026-05-18
Read third time. Passed. (Ayes 29. Noes 0. Page 4312.) Ordered to the Assembly.
passage,reading-1,reading-3
2026-05-14
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2026-05-14
From committee: Do pass. (Ayes 5. Noes 0. Page 4261.) (May 14).
committee-passage,committee-passage-favorable
2026-05-08
Set for hearing May 14.
2026-04-20
April 20 hearing: Placed on APPR. suspense file.
2026-04-10
Set for hearing April 20.
2026-04-09
From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0. Page 3793.) (April 8). Re-referred to Com. on APPR.
committee-passage,committee-passage-favorable,referral-committee
2026-03-26
Set for hearing April 8.
2026-03-25
Re-referred to Com. on HEALTH.
referral-committee
2026-03-16
From committee with author's amendments. Read second time and amended. Re-referred to Com. on RLS.
amendment-passage,committee-passage,reading-1,reading-2,referral-committee
2026-02-18
Referred to Com. on RLS.
referral-committee
2026-02-11
From printer. May be acted upon on or after March 13.
2026-02-10
Introduced. Read first time. To Com. on RLS. for assignment. To print.
introduction,reading-1,referral-committee
Versions
Documents
- application/pdf
- application/pdf
- text/html
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf
- application/pdf
- application/pdf
Votes
Do pass, but first be re-referred to the Committee on [Appropriations]
2026-04-08 · pass · 9-0
Member-level votes (11)
- Rubio: yes
- Smallwood-Cuevas: yes
- Padilla: yes
- Caballero: yes
- Durazo: yes
- Menjivar: yes
- Gonzalez: yes
- Weber Pierson: yes
- Pérez: yes
- Valladares: other
- Grove: other
Placed on suspense file
2026-04-20 · pass · 7-0
Member-level votes (7)
- Cervantes: yes
- Dahle: yes
- Wahab: yes
- Cabaldon: yes
- Grayson: yes
- Richardson: yes
- Seyarto: yes
Do pass
2026-05-14 · pass · 5-0
Member-level votes (7)
- Wahab: yes
- Cervantes: yes
- Cabaldon: yes
- Richardson: yes
- Grayson: yes
- Dahle: other
- Seyarto: other
3rd Reading SB1023 Laird et al.
2026-05-18 · pass · 29-0
Member-level votes (40)
- Caballero: yes
- Hurtado: yes
- Laird: yes
- Cervantes: yes
- Ashby: yes
- Durazo: yes
- Umberg: yes
- Wahab: yes
- Arreguín: yes
- Menjivar: yes
- Weber Pierson: yes
- Cortese: yes
- Rubio: yes
- Blakespear: yes
- McGuire: yes
- Becker: yes
- Smallwood-Cuevas: yes
- Stern: yes
- Limón: yes
- McNerney: yes
- Cabaldon: yes
- Wiener: yes
- Pérez: yes
- Reyes: yes
- Allen: yes
- Archuleta: yes
- Gonzalez: yes
- Grayson: yes
- Richardson: yes
- Alvarado-Gil: other
- Grove: other
- Choi: other
- Strickland: other
- Valladares: other
- Jones: other
- Ochoa Bogh: other
- Niello: other
- Dahle: other
- Seyarto: other
- Padilla: other
Do pass and be re-referred to the Committee on [Appropriations]
2026-06-09 · pass · 11-0
Member-level votes (16)
- Stefani: yes
- Carrillo: yes
- Sharp-Collins: yes
- Bonta: yes
- Ahrens: yes
- Elhawary: yes
- Addis: yes
- Caloza: yes
- Celeste Rodriguez: yes
- Aguiar-Curry: yes
- Patel: yes
- Sanchez: other
- Patterson: other
- Chen: other
- Johnson: other
- Schiavo: other
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-09-30T05:37:17.290753Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=SB 1023. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.